Publication related to RSI or an RSI staff member

Statistical analysis of lacZ mutant frequency data from MutaMouse mutagenicity assays.

Authors

  • Fung, K Y, Fung KY, Department of Mathematics and Statistics, University of Windsor, Ontario, Canada. kfung@uwindsor.ca

  • Douglas, G R, Douglas GR,

  • Krewski, D, Krewski D,

YEAR OF PUBLICATION: 1998
SOURCE: Mutagenesis. 1998 May;13(3):249-55. doi: 10.1093/mutage/13.3.249.
JOURNAL TITLE ABBREVIATION: Mutagenesis
JOURNAL TITLE: Mutagenesis
ISSN: 0267-8357 (Print) 0267-8357 (Linking)
VOLUME: 13
ISSUE: 3
PAGES: 249-55
PLACE OF PUBLICATION: England
ABSTRACT:

Transgenic mouse assays have provided an unprecedented opportunity to study mutagenesis in diverse rodent tissues. In this article data from MutaMouse mutagenicity assays based on the Escherichia coli gene lacZ were analyzed systematically using liver and bone marrow as potential target tissues. Sources of variation, including plates (within packaging reactions), packaging reactions (within animals) and animals, were evaluated for extra-binomial variation. Although hardly any evidence of overdispersion was detected at the plate level, limited evidence of extra-binomial variation was observed at the packaging reaction level. There was, however, much stronger evidence of overdispersion at the animal level. Statistical tests for increasing trend in mutant frequency with increasing dose were also performed at the animal level. A significant increasing trend following exposure to N-nitrosodibenzylamine was detected in liver but not in bone marrow. A logistical model was used to further describe the dose-response relationship observed in N-nitrosodibenzylamine-treated liver tissue.

LANGUAGE: eng
DATE OF PUBLICATION: 1998 May
DATE COMPLETED: 19990415
DATE REVISED: 20190512
MESH DATE: 1998/06/27 00:01
EDAT: 1998/06/27 00:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski